Unknown

Dataset Information

Topical Fluoxetine as a Novel Therapeutic That Improves Wound Healing in Diabetic Mice.


ABSTRACT: Diabetic foot ulcers represent a significant source of morbidity in the U.S., with rapidly escalating costs to the health care system. Multiple pathophysiological disturbances converge to result in delayed epithelialization and persistent inflammation. Serotonin (5-hydroxytryptamine [5-HT]) and the selective serotonin reuptake inhibitor fluoxetine (FLX) have both been shown to have immunomodulatory effects. Here we extend their utility as a therapeutic alternative for nonhealing diabetic wounds by demonstrating their ability to interact with multiple pathways involved in wound healing. We show that topically applied FLX improves cutaneous wound healing in vivo. Mechanistically, we demonstrate that FLX not only increases keratinocyte migration but also shifts the local immune milieu toward

SUBMITTER: Nguyen CM 

PROVIDER: S-EPMC6609984 | biostudies-literature | 2019 Jul

REPOSITORIES: biostudies-literature